从菌体到逃生:针对MDR感染的个性化治疗-全面的临床审查
Andrea Marino1, Stefano Stracquadanio2, Federica Cosentino1
1Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, University of Catania, 95122 Catania, Italy.
Pathogens (Basel, Switzerland)
|October 29, 2025
概括
菌体疗法对治疗多抗药性ESKAPE病原体充满希望,提供个性化的方法. 菌体治疗的挑战包括宿主范围和调节,但菌体-抗生素协同作用和尾酒是关键策略.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 病毒学 病毒学
背景情况:
- 多药耐药 (MDR) ESKAPE病原体构成了全球严重的健康威胁.
- 传统的抗生素对这些耐药细菌的有效性越来越低.
- 菌体治疗正在重新成为一种潜在的治疗策略.
研究的目的:
- 审查细菌治疗对抗MDRESKAPE病原体的潜力.
- 综合临床前和临床证据,以证明菌体治疗的有效性.
- 确定菌体疗法实施的挑战和未来方向.
主要方法:
- 关于临床前和临床研究的综合文献综述.
- 分析用于菌体治疗的同情使用案例.
- 对菌体特异性,自我复制和生物膜活动的评估.
主要成果:
- 菌体疗法表现出成功,特别是在无法治疗的感染的救援病例中.
- 优点包括特异性,自我复制和抗生物膜活性.
- 挑战包括狭窄的宿主范围,细菌耐药性,药理动力学和监管障碍.
结论:
- 菌体治疗是对抗MDR感染的有希望的辅助工具,而不是替代抗生素.
- 菌体-抗生素协同作用和菌体尾酒可以克服限制.
- 标准化制造,临床试验和适应性法规对于未来的进步至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Lytic Cycle of Bacteriophages
77.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.4K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


